Skip to main content
. Author manuscript; available in PMC: 2013 Aug 6.
Published in final edited form as: Ann Thorac Surg. 2013 Jun 15;96(2):586–595. doi: 10.1016/j.athoracsur.2013.04.021

Fig. 2.

Fig. 2

(A) Changes in stroke volume index (mL/m2) over time. †p<0.05 for difference from 3-week to 12-week time points in either the control group or the molecular cardiac surgery with recirculating delivery (MCARD) group. ‡p<0.05 for difference between MCARD and control groups at 12 weeks. (B) Changes in ejection fraction (%) over time. †p<0.05 for difference from 3-week to 12-week time points in either the control group or the MCARD group. ‡p<0.05 for difference between MCARD and control groups at 12 weeks.

HHS Vulnerability Disclosure